Strategic question
Is our existing Digital Health portfolio fit for purpose against our updated franchise strategy?
How Galen Growth helped
From market signal to decision-ready evidence
Working closely with franchise and BD teams, we used HealthTech Alpha to evaluate 70+ existing venture partnerships against clinical, commercial and operational maturity criteria.
Outcomes
Surfaced which partnerships were genuinely scaling value, which were underperforming and which had become strategically misaligned.
Decision enabled: Enabled franchise leadership to re-prioritise, retire or deepen existing partnerships with confidence.
Key results
Our approach
A repeatable path to a defensible decision
Define
Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map
Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.
Assess
Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide
Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.
Related work
More digital health case studies
Tracking Competitor Moves to Support Global Franchise Strategy
How should we track competitor activity across obesity, diabetes and cardiovascular disease to support global strategic decisions?
Prioritising Markets and Partners to Accelerate a Women’s Health Roadmap
Which priority markets and venture partners should anchor our future women’s health innovation roadmap, starting with telemedicine?
Benchmarking Global Competitor Partnerships to Prioritise Digital Health Strategy
Where are competitors investing and partnering in Digital Health, and what should that mean for our own portfolio strategy?